Accumulating evidence demonstrates that tumor cell-derived adenosine, within the TME, binds its cognate receptor, A2aR, on the surface of T cells leading to their impaired tumoricidal reactivity through triggering downstream signaling cascades (148). The gene discussed is ADORA2A; the disease is neoplasm.